Search research articles
Contact Us
Filters
Showing results (341-350 of 470) with videos related to
Page
of 47
Sort By:
Antioxidants & Redox Signaling
|
February 15, 2023
Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in Colorectal Cancer
Nicholas J Lyons, Rabina Giri, Jakob Begun, et al.
The Journal of Biological Chemistry
|
September 2, 2000
Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4
T J Harvey, J D Hooper, S A Myers, et al.
Molecular Pharmaceutics
|
January 19, 2026
Indocyanine Green-Labeled Antibodies Cotargeting CDCP1 and Mesothelin for Fluorescence-Guided Imaging of Pancreatic Cancer
Johnny X Huang, Biao Sun, William McGahan, et al.
The Journal of Biological Chemistry
|
February 9, 2012
The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration
Ying Dong, Yaowu He, Leonore de Boer, et al.
Clinical Science (London, England : 1979)
|
June 23, 2019
Ovarian cancer-derived exosomes promote tumour metastasis <i>in vivo</i>: an effect modulated by the invasiveness capacity of their originating cells
Mona Alharbi, Andrew Lai, Dominic Guanzon, et al.
BMC Medical Genetics
|
December 21, 2012
Genome-wide sequencing for the identification of rearrangements associated with Tourette syndrome and obsessive-compulsive disorder
Sean D Hooper, Anna C V Johansson, Christian Tellgren-Roth, et al.
Biochemistry
|
February 26, 2000
The spasmodic peptide defines a new conotoxin superfamily
M B Lirazan, D Hooper, G P Corpuz, et al.
Biological Chemistry
|
July 17, 2008
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)
Andrew J Ramsay, Janet C Reid, Mark N Adams, et al.
Pharmacology & Therapeutics
|
February 1, 2011
Structure, function and pathophysiology of protease activated receptors
Mark N Adams, Rithwik Ramachandran, Mei-Kwan Yau, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1975
Plasma protein binding of carbamazepine
W D Hooper, D K Dubetz, F Bochner, et al.
Page
of 47
Search research articles
Search
Showing results (341-350 of 470) with videos related to
Sort By:
Page
of 47
Antioxidants & Redox Signaling
|
February 15, 2023
Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in Colorectal Cancer
Nicholas J Lyons, Rabina Giri, Jakob Begun, et al.
The Journal of Biological Chemistry
|
September 2, 2000
Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4
T J Harvey, J D Hooper, S A Myers, et al.
Molecular Pharmaceutics
|
January 19, 2026
Indocyanine Green-Labeled Antibodies Cotargeting CDCP1 and Mesothelin for Fluorescence-Guided Imaging of Pancreatic Cancer
Johnny X Huang, Biao Sun, William McGahan, et al.
The Journal of Biological Chemistry
|
February 9, 2012
The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration
Ying Dong, Yaowu He, Leonore de Boer, et al.
Clinical Science (London, England : 1979)
|
June 23, 2019
Ovarian cancer-derived exosomes promote tumour metastasis <i>in vivo</i>: an effect modulated by the invasiveness capacity of their originating cells
Mona Alharbi, Andrew Lai, Dominic Guanzon, et al.
BMC Medical Genetics
|
December 21, 2012
Genome-wide sequencing for the identification of rearrangements associated with Tourette syndrome and obsessive-compulsive disorder
Sean D Hooper, Anna C V Johansson, Christian Tellgren-Roth, et al.
Biochemistry
|
February 26, 2000
The spasmodic peptide defines a new conotoxin superfamily
M B Lirazan, D Hooper, G P Corpuz, et al.
Biological Chemistry
|
July 17, 2008
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)
Andrew J Ramsay, Janet C Reid, Mark N Adams, et al.
Pharmacology & Therapeutics
|
February 1, 2011
Structure, function and pathophysiology of protease activated receptors
Mark N Adams, Rithwik Ramachandran, Mei-Kwan Yau, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1975
Plasma protein binding of carbamazepine
W D Hooper, D K Dubetz, F Bochner, et al.
Page
of 47